The Future of Autism Care: Global Advanced Infusion System Market
Author : Bhushan S | Published On : 07 May 2024
The advanced infusion system market is anticipated to increase in value from US$ 8,862.8 million in 2023 to US$ 16,536.9 million in 2033. Over the course of the forecast period, advanced infusion system sales are anticipated to grow at a noteworthy CAGR of 6.4%.
Preview Next-Level Insights Sample :
https://www.futuremarketinsights.com/reports/sample/rep-gb-2026
Precise Dosing and Enhanced Patient Safety: Advanced Infusion Systems Take Center Stage
The global advanced infusion systems market is experiencing significant growth, driven by the growing demand for accurate and controlled medication delivery. These advanced systems offer significant advantages over traditional methods, promoting wider adoption within the healthcare field.
Tailored Treatments for Diverse Needs
Advanced infusion systems allow for the administration of fluids and medications through various routes, including:
- Subcutaneous: Delivery of medication just beneath the skin.
- Epidural: Delivery of medication into the epidural space, near the spinal cord.
- Enteral: Delivery of nutrition directly into the stomach or small intestine.
- Intravenous: Delivery of medication directly into the bloodstream.
Key Takeaways:
- The global advanced infusion systems market is projected to reach US$16,536.9 million by 2033, reflecting a significant rise from US$8,862.8 million in 2023.
- This growth is anticipated at a healthy compound annual growth rate (CAGR) of 6.4% throughout the forecast period.
- The increasing adoption of advanced infusion systems for precise and controlled drug delivery is a key driver for market expansion.
Competitive Landscape:
Important Market Players Making Various Efforts to Gain an Advantage
The major players in the market for advanced infusion systems are always working together and putting out great effort to develop high-end infusion systems that will help patients by providing them with more sophisticated and equipped solutions.
Recent Developments
In January 2020, Medtronic (Ireland) Launched Efficio, a cloud-based data management software, for use with the SynchroMed II intrathecal drug delivery system. This enables clinicians to efficiently manage their targeted drug delivery pump practices to treat patients with chronic pain, cancer, and severe spasticity.
In March 2020, Q Core Medical Company opened a new manufacturing unit in Europe to capitalize on the opportunities offered by the advanced infusion systems market due to the increasing geriatric population and increasing demand for the adoption of infusion systems in healthcare, therapeutic effectiveness, and reliability.
Key Companies Profiled:
- TERUMO CORPORATION
- AIS HealthCare
- B. Braun Medical Ltd
- Medtronic
- Baxter
- MOOG INC.
- armed ag
- AVA Biomedical
- BD
- Smiths Group plc.
Advanced Infusion System Market:
By Product:
- Elastomeric Infusion System
- Volumetric Infusion System- Large Volume and Small Volume Pump
- Patient Controlled Analgesia pump
- Disposable Infusion System
- Syringe Infusion System
- Ambulatory Infusion System
- Implantable Infusion System
By Application:
- Chemotherapy
- Diabetes
- Pain management
- Asthma
- Clinical Nutrition
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic centers
- Bedside
By Region:
- North America
- Latin America
- Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa (MEA)
